Anzeige
Mehr »
Donnerstag, 05.06.2025 - Börsentäglich über 12.000 News
Kupfer wird knapp! Jetzt mischen sich Medien ein - und ein Explorer liefert die Story zur Fantasie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PXUH | ISIN: FR0013470168 | Ticker-Symbol: IM11
Frankfurt
05.06.25 | 09:10
0,093 Euro
-3,71 % -0,004
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
IMPLANET SA Chart 1 Jahr
5-Tage-Chart
IMPLANET SA 5-Tage-Chart
RealtimeGeldBriefZeit
0,0970,09911:54

Aktuelle News zur IMPLANET Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
24.04.IMPLANET to Co-Exhibit its Innovative Spine Solutions Alongside 8i Robotics' Next-Gen Robotic Solutions at AANS in Boston222Spine tech innovator IMPLANET will demo and display its game-changing portfolio in tandem with 8i Robotics' robot systems at Booth #1029, April 25-28, 2025 Regulatory News: At this year's American...
► Artikel lesen
IMPLANET Aktie jetzt für 0€ handeln
14.04.Minutes of IMPLANET's Annual General Meeting Held on April 11, 2025382Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, éligible PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced...
► Artikel lesen
09.04.IMPLANET Reports Revenue of €2.58 Million in Q1 2025, Up +16%230+16% revenue growth compared to Q1 2024 Performance driven by strong export growth outside France and the United States (+42% vs. Q1 2024) Regulatory News: IMPLANET (Euronext Growth:...
► Artikel lesen
04.03.IMPLANET Reports Its 2024 Full-Year Results3682024 full-year revenue up +26% compared to fiscal year 2023 Continued strict control of operational costs throughout the period Regulatory News: IMPLANET (Euronext Growth: ALIMP,...
► Artikel lesen
14.01.IMPLANET Announces 2024 Full-Year Revenue Up 26% to €9.4 Million363Continued acceleration in quarterly revenue growth since Q2 2024, with Q4 2024 reaching nearly €3.0 million, up 81% versus 2023 Strong full-year performance in the medical equipment distribution...
► Artikel lesen
06.01.IMPLANET Announces Its 2025 Financial Calendar457Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in implants for orthopedic surgery and the...
► Artikel lesen
05.12.24IMPLANET Announces Financing of Around €2 Million415Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in implants for orthopedic surgery and the...
► Artikel lesen
08.10.24IMPLANET announces revenue of €2.3 million as of September 30, 2024, 50% growth416Revenue for the first nine months of 2024: €6.4 million, a 11% increase compared to the same period last year First delivery of Olea equipment worth €0.5 million completed in the United...
► Artikel lesen
25.09.24elliquence and Implanet Form Partnership for US Distribution of Ultrasonic Bone Scalpel Olea in Endoscopic Spine Market418Spine tech innovators elliquence and Implanet to exhibit at NASS in Chicago, September 25-28, 2024 (elliquence LLC Booth 2419 Implanet Booth 2412) Regulatory News: elliquence LLC, specializing...
► Artikel lesen
19.09.24Implanet to Co-Exhibit Alongside 8i Robotics' Next-Gen Robotic Solutions at NASS1 booth #2412 in Chicago557Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced...
► Artikel lesen
10.09.24IMPLANET Announces Its 2024 Half-year Results525Revenue of €4.1 million in the first half of 2024 Sales force investment aimed at revitalizing the Company's presence in the United States Strict management of operational expenses...
► Artikel lesen
09.07.24IMPLANET Reports Revenue of €4.1 Million in the First Half of 2024520Continued growth momentum in the French market Strong progress in medical equipment sales, +81% vs. H1 2023 Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible...
► Artikel lesen
12 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1